Wells Fargo raises PTC Therapeutics target price to $112 from $109
PTCT•Wells Fargo raised its target price for PTC Therapeutics to $112 from $109.
Related News
Exxon, Chevron earnings propelled by war-driven refining surge
XOM•
First Solar: Susquehanna cuts target price to $246 from $270
FSLR•
Canada's economic growth stalls again in August, September likely a decline
SPY•
Verra Mobility names Matthew Kvarda interim CFO
VRRM•
Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
QQQ•